Table 2.
Aerosol | Exposure | Nicotine In the chamber (μg/m3) | Source of Aerosol | Aerosol Level (mg/m3) | Organ | Exposed (n=10)/unexposed (n=10) | |||
---|---|---|---|---|---|---|---|---|---|
γ-OH-PdG/105 dG | α-methyl-γ −OH-PdG/105 dG | O6-me-dG/107 dG | BPDE-dG/107 dG | ||||||
MTS1 | 3 cig4 6 h/d 5 d/wk 12 wks |
871.5 |
2R4F cig 2 puffs/min 35 ml/puff |
75 |
Lung | 0.55/0.05**** | 0.19/ND | 0.05/0.25 ns | 0.75/0.75 ns |
Heart | 0.15/0.15 ns | ----- | 0.3/0.4 ns | 0.4/0.4 ns | |||||
Liver | 0.4/0.3 ns | ----- | 0.075/0.07 5 ns |
0.6/0.6 ns | |||||
Bladder | 0.3/0.05*** | ND/ND | 0.2/0.1 ns | 0.2/0.1 ns | |||||
SSS2 | 3 cig4 6 h/d 5 d/wk 16 wks |
36 |
2R4F cig 2 puffs/min 35 ml/puff |
0.454 |
Lung | 0.5/0.3* | ND | 2/2 ns | |
Heart | 0.05/0.05 ns | ----- | 2/2 ns | ||||||
Liver | 0.4/0.35 ns | ----- | 2/1.75 ns | ||||||
Bladder | 0.7/0.4** | ND | 1.8/1.7 ns | ||||||
ECA3 | E-liquid (Nicotine 10 mg/ml +PG and VG) 3 h/d 5 d/wk 12 wks |
129 |
E-juice (nicotine, PG and VG) puffs/min 35 ml/puff |
130 |
Lung | 1/0.2*** | ND | 4/0.2**** | ----- |
Heart | 0.3/0.05**** | ----- | 0.5/0.1*** | ----- | |||||
Liver | 0.04/0.035 ns | ----- | 1/1 ns | ---- | |||||
Bladder | 0.4/0.05*** | ND | 1.25/0.2** | ---- |